Globally, similar patent expiries in China, Canada, and beyond will amplify this, potentially reaching 40% of the worlds population with affordable GLP-1 options
Across much of the region, GLP-1 therapies are more likely to be driven by diabetes and metabolic disease management than for weight loss. That demand profile has already started to shift
I would say I'm a fighter because I've been through so much
Different researchers have established the importance of ferroptosis in suppressing tumor cell proliferation and eliminating them
Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes
Subsequently, to further extend the effect of exenatide, Amylin and Eli Lilly developed exenatide injectable microspheres (Bydureon), which was approved in the United States in January 2012